Wu et al. developed a light-inducible CRISPR/Cas9 system to cleave the mutated BRAF gene (BRAF V600E), which promotes melanoma cell apoptosis and effectively inhibits melanoma cell proliferation, invasion, and migration (Wu et al., 2020). The gene discussed is BRAF; the disease is melanoma.